Show simple item record

dc.contributor.authorAnderson, Frederick A. Jr.
dc.contributor.authorWhite, Kami
dc.date2022-08-11T08:08:09.000
dc.date.accessioned2022-08-23T15:44:22Z
dc.date.available2022-08-23T15:44:22Z
dc.date.issued2002-08-17
dc.date.submitted2011-11-03
dc.identifier.citationSemin Thromb Hemost. 2002 Aug;28 Suppl 3:43-6. <a href="http://dx.doi.org/10.1055/s-2002-34075">Link to article on publisher's site</a>
dc.identifier.issn0094-6176 (Linking)
dc.identifier.doi10.1055/s-2002-34075
dc.identifier.pmid12232823
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27297
dc.description.abstractThe U.S. Hip and Knee Registry is a voluntary national registry of outcome data for hip and knee surgery. In total, 469 orthopedic surgeons from 325 hospitals reported data on 7677 patients who underwent total hip arthroplasty (THA) and 11,461 patients who underwent total knee arthroplasty (TKA). Data on patients enrolled between 1996 and 2000 indicate that 40% of THA patients and 42% of TKA patients received prophylaxis for a period of 8 to 21 days, including the in-hospital period. Prolonged prophylaxis for more than 21 days was used in 49% of THA patients and 44% of TKA patients. Moreover, year on year, data indicate that the percentage of patients who receive prophylaxis for longer than 21 days is gradually increasing. In 2000, 53% of THA patients and 47% of TKA patients received prophylaxis for longer than 21 days.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=12232823&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1055/s-2002-34075
dc.subjectAged
dc.subject*Arthroplasty, Replacement, Hip
dc.subject*Arthroplasty, Replacement, Knee
dc.subjectBandages
dc.subjectCombined Modality Therapy
dc.subjectDrug Utilization
dc.subjectFemale
dc.subjectFibrinolytic Agents
dc.subjectHeparin, Low-Molecular-Weight
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPostoperative Complications
dc.subjectPostoperative Period
dc.subjectPulmonary Embolism
dc.subjectRegistries
dc.subjectThrombosis
dc.subjectUnited States
dc.subjectHealth Services Research
dc.subjectOrthopedics
dc.titleProlonged prophylaxis in orthopedic surgery: insights from the United States
dc.typeJournal Article
dc.source.journaltitleSeminars in thrombosis and hemostasis
dc.source.volume28 Suppl 3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cor_hipknee/1
dc.identifier.contextkey2328947
html.description.abstract<p>The U.S. Hip and Knee Registry is a voluntary national registry of outcome data for hip and knee surgery. In total, 469 orthopedic surgeons from 325 hospitals reported data on 7677 patients who underwent total hip arthroplasty (THA) and 11,461 patients who underwent total knee arthroplasty (TKA). Data on patients enrolled between 1996 and 2000 indicate that 40% of THA patients and 42% of TKA patients received prophylaxis for a period of 8 to 21 days, including the in-hospital period. Prolonged prophylaxis for more than 21 days was used in 49% of THA patients and 44% of TKA patients. Moreover, year on year, data indicate that the percentage of patients who receive prophylaxis for longer than 21 days is gradually increasing. In 2000, 53% of THA patients and 47% of TKA patients received prophylaxis for longer than 21 days.</p>
dc.identifier.submissionpathcor_hipknee/1
dc.contributor.departmentCenter for Outcomes Research
dc.source.pages43-6


This item appears in the following Collection(s)

Show simple item record